Teva Pharmaceutical Industries Ltd ADR buy UBS Group AG
Start price
27.11.23
/
50%
€8.94
Target price
27.11.24
€11.87
Performance (%)
69.46%
Price
08.07.24
€15.15
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR has seen massive gains of 69.46%. This prediction currently runs until 27.11.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teva Pharmaceutical Industries Ltd ADR | -0.329% | -0.329% |
iShares Core DAX® | 1.395% | -0.272% |
iShares Nasdaq 100 | 2.287% | 6.912% |
iShares Nikkei 225® | 1.617% | 3.038% |
iShares S&P 500 | 0.659% | 3.687% |
Comments by UBS_Group_AG for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $11.00.
Ratings data for TEVA provided by MarketBeat